TBT BSN | Notification

Notification Detail :: G/TBT/N/AUS/167

Notification No.

Notification Type

Notifying Member

Date of Notification

Final Date for Comments

Days to Final Date

Title

Pharmaceutical Inspection Co-operation Scheme (PIC/S) Guide to Good Manufacturing Practice for Medicinal Products, 1 February 2022, PE-009- 16

Objective

Harmonization (TBT)

Product Covered

Medicines

Document Notification

Link to ePing

HSCODE

30 - PHARMACEUTICAL PRODUCTS

ICSCODE

11.120 - Pharmaceutics

Keywords

Human health

Specific Regions

Description

The Therapeutic Goods Administration (TGA) administers Australia’s regulatory framework for the quality, safety, efficacy of therapeutic goods in Australia.There are provisions under the Therapeutic Goods Act 1989 (the Act) to establish Manufacturing Principles that are to be applied in the manufacture of therapeutic goods. The Therapeutic Goods (Manufacturing Principles) Determination 2020 (the Determination) is the legislative instrument that specifies the manufacture of therapeutic goods must comply with the applicable procedures and requirements in the Pharmaceutical Inspection Co-operation Scheme (PIC/s) Guide to GMP.  As a PIC/S member, Australia is expected to adopt and enforce the latest revisions to the GMP guide to achieve international harmonisation between member countries.  Adoption of the PIC/S Guide to GMP as Australia’s Manufacturing Principles negates the need for Australian-specific standards, facilitates international trade and supports our international reputation.The adoption of an internationally harmonised standard minimises regulatory burden for companies involved in the manufacture, import and export of medicines, facilitating trade and helping to ensure the availability of medicines to the Australian public.

Notified Document

1:File here

Link to Notification

EN:File here

Status Active

No	#	Comment By	Title	Comment Date	File

Back

Notification Detail :: G/TBT/N/AUS/167

Link to ePing

App Settings